When it does, the introduction of stem cell medicines will have a profound effect on the practice of medicine, and we can expect cocktail conversations to revolve around the potential stem cells have for saving lives, rather than beginning them.
Its goal is to create pills that unlock the potential of stem cells already situated inside the brain, skin, and bone marrow.
There is potential that stem cells could help replace diseased, damaged or dying cells and contribute towards improved function of that person's organs, possibly representing a cure for the disease from which they suffered.
Initially Grove was enthusiastic about the potential of embryonic stem cells as a treatment.
Thompson at a Senate hearing on the potential of embryonic stem cells.
Research involving human embryonic stem cells and human non-embryonic stem cells has the potential to lead to better understanding and treatment of many disabling diseases and conditions.
Scientists working on embryos say that stem cell research is in its infancy and not enough is known about the potential of either adult or embryonic stem cells to abandon one approach in favour of the other.
One of the difficulties of making patient-specific pluripotent stem cells for potential therapeutic use is that the process is so time consuming.
FORBES: Scientist Shows How Small Molecules Generate Better Stem Cells
Many scientists believe embryonic stem cells have remarkable potential for treating human diseases.
Adult stem cells have great potential as cell sources for regenerative medicine.
Embryonic stem cells have great potential for treating human disease because of their ability to generate almost all the cell types found in the adult body.
Researchers highly value embryonic stem cells because of their potential to turn into any organ or tissue cell in the body.
But currently there remain too many unresolved problems with their generation, and embryonic stem cells are considered a necessary tool in the continued research on how to perfect iPS cells for potential therapeutic use.
FORBES: Scientists Relieved As Supreme Court Passes Over Case Against Embryonic Stem Cell Research
Now, the pharmaceutical industry is increasingly adopting stem cells for testing the toxicity of drugs and identifying potential new therapies, say those in the field.
Embryonic stem cells are seen by many researchers as having great potential because they can in theory be coaxed to create any kind of cell type in the body.
Stem cell therapies have the potential to surpass monoclonal antibodies because they use cells doing what cells normally do to stimulate the body to do what it normally does.
Only last year, she said, Egli and Paull and their colleagues demonstrated that the nuclear transfer of eggs cells could generate patient-specific stem cell lines for potential cell replacement therapy to treat diseases like diabetes.
FORBES: Nuclear Transfer Breakthrough Offers A Way To Prevent Mitochondrial Disorders
Then there's a completely new idea, which is to generate a kind of a cell that you would merge with a kind of an egg, and you'd get something that was kind of an embryo but it wasn't really an embryo, and it wouldn't have the potential to grow into anything, and maybe those would give rise to stem cells.
They said research using adult stem cells, the field each of them works in, has more potential to help patients.
The debate about embryonic stem cells was good example: proponents had Christopher Reeve walking, and opponents minimized their potential.
Embryonic stem cells have also caught the eye of drug companies, which aim to use them to test potential drugs for effectiveness and toxicity.
First came the remarkable work of Shinya Yamanaka at Kyoto University, who showed it was possible, by activating just four genes, to take a mature cell (he used a bit of skin but other cells would work) and turn it into the equivalent of an embryonic stem cell with the potential to become any other cell in the body of mouse or human.
应用推荐